Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
The recent trial assessing CSL112’s role in enhancing cholesterol efflux capacity showed no significant reduction in cardiovascular events over one year among patients post-acute myocardial infarction, maintaining a safety profile consistent with placebo.
Cardiology May 8th 2024
In a recent study among low-risk aortic stenosis patients, transcatheter aortic-valve implantation (TAVI) demonstrated a significant reduction in the combined endpoint of death or stroke at one year compared to surgical replacement, suggesting its potential as a safer alternative in selected patient groups.
UT Southwestern Medical Center
This study at UT Southwestern shows that vaginal misoprostol could reduce the oxytocin requirement in labor induction, enhancing care efficiency without compromising patient safety.
Obstetrics & Gynecology May 2nd 2024
MDLinx
The integration of AI in skin cancer diagnostics not only improves the accuracy of diagnoses—achieving a sensitivity of 81.1% and specificity of 86.1%—but also supports the broader application of AI tools in enhancing patient care across various medical specialties.
Dermatology April 22nd 2024
TheBodyPro
The “Effectiveness of PrEPTECH” trial reveals telehealth’s potential and challenges in initiating and sustaining PrEP adherence among at-risk groups, emphasizing the necessity for integrated community support in healthcare strategies.
Infectious Diseases April 22nd 2024
Recent findings demonstrate that among patients with small aortic annuli undergoing TAVR, those treated with self-expanding valves experienced significantly lower rates of bioprosthetic-valve dysfunction (9.4%) compared to those with balloon-expandable valves (41.6%), emphasizing the necessity for careful valve selection in clinical practice.
Cardiology April 19th 2024